secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001193125-25-004443
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Rein Therapeutics (formerly Aileron) changes name to Rein Therapeutics, new ticker RNTX
--------------------------------------------------------------------------------

- Name change from Aileron Therapeutics to Rein Therapeutics effective January 10, 2025 at 4:00 p.m. Eastern Time.
- New trading symbol RNTX on Nasdaq Capital Market; trading under new name and symbol starts January 13, 2025.
- CUSIP number for common stock remains unchanged; no impact on stockholder rights.
- Certificate of amendment and amended bylaws filed as exhibits to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525004443/0001193125-25-004443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525004443/d898488d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-004443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer